Correlation Between Qualigen Therapeutics and Canfor

Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Canfor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Canfor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Qualigen Therapeutics and Canfor, you can compare the effects of market volatilities on Qualigen Therapeutics and Canfor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Canfor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Canfor.

Diversification Opportunities for Qualigen Therapeutics and Canfor

-0.32

Correlation Coefficient

Qualigen Therapeutics  Canfor

Very good diversification

The 3 months correlation between Qualigen and Canfor is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Canfor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canfor and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Canfor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canfor has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Canfor go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Canfor

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Canfor. In addition to that, Qualigen Therapeutics is 3.03 times more volatile than Canfor. It trades about -0.12 of its total potential returns per unit of risk. Canfor is currently generating about 0.14 per unit of volatility. If you would invest  1,063  in Canfor on August 31, 2024 and sell it today you would earn a total of  221.00  from holding Canfor or generate 20.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Qualigen Therapeutics  vs.  Canfor

Qualigen Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Canfor

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Canfor are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Canfor reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Qualigen Therapeutics and Canfor

The main advantage of trading using opposite Qualigen Therapeutics and Canfor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Canfor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canfor will offset losses from the drop in Canfor's long position.

The idea behind Qualigen Therapeutics and Canfor pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.